In this article:
Protocol development in integrative medicine is not typically a simple process. Individuals require individualized care, and what works for one patient may not work for another.
As a result, the Fullscript Integrative Medical Advisory team advises using an evidence-informed approach to protocol development. To simplify this process for practitioners, we have assembled a sampling of evidence-based standardized protocols that practitioners can use as a foundation when developing individualized protocols.
To establish these protocols, we first developed a Rating Scale that could be used to discern the rigor of evidence supporting a specific nutrient’s therapeutic effect.
The following protocols were developed using only A through C-quality evidence. These are categorized as follows:
A Systematic review or meta-analysis
B Randomized Double Blind Placebo Controlled (RDBPC) 2+ studies and/or 1 study with 50 + subjects
C Randomized Double Blind Placebo Controlled (RDBPC) 1 study
Please refer to the complete Rating Scale for further information.
The ingredients included in these protocols are based on a review of existing clinical research, with a priority placed on systematic reviews and meta-analyses, classified as A in the Rating Scale.
These protocols are intended to form a foundation for developing individualized treatment plans. Clinician discretion is highly advised, as ingredients can vary in safety and effectiveness, depending on the needs of the individual patient.
Ingredient-Based Protocol: Benign Prostatic Hyperplasia
Saw Palmetto (Serenoa repens)
320-960mg, total per day, minimum 3 to 5.5 months1,2
- Decrease in inflammatory markers that contribute to the evolution of chronic prostatic inflammation and subsequent hyperplasia1
- Saw Palmetto supplementation resulted in an increase in average flow rate values, and decreases in prostate volume and IPSS score3
Search for Saw Palmetto in the Fullscript catalog.
15mg, total per day, minimum 6 months4
- Reduction in PSA levels and overall improvement of IPSS score5
- Consistent lycopene supplementation has been shown to inhibit the overall progression of BPH5
Search for Lycopene in the Fullscript catalog.
130mg, total per day, minimum 6 months6
- Beta-sitosterol has been shown to improve IPSS score8
- Overall improvement of quality of life (QOL), urinary and flow scores, which include maximum urinary flow and postvoid residual urine volume7,8
Search for Beta-sitosterol in the Fullscript catalog.
Adding Protocols to your Fullscript Catalog
Create a Template
- Click the “Prescriptions” button
- Click “Manage your prescription templates”
- Click “Create a new template”
- Add a title, products, dosing, message, and attachments
- Click “Save Template”
Templates can be accessed and applied when creating a new prescription for your patients.
Write a Prescription
- Click the “New Prescription” button
- Click the “Templates” button in the right-hand menu column
- Click the “Apply” button beside the template you wish to apply
- Modify as needed
- Click the “Send to Patient” button!
Create a Category
- Click the Catalog button
- Click the “Your Favorites” tab
- Click “Add Category” and add name
- Add products
Categories can be used for quick reference or for patient use when accessing the catalog (depending on catalog settings).
Visit the Fullscript Integrative Clinical Education Hub for a full review of the literature used to develop this protocol.
We’d be happy to help you create a protocol containing these ingredients in your Fullscript catalog! Contact our Customer Success team for assistance.
1 (C) - https://www.ncbi.nlm.nih.gov/pubmed/26891611
2 (B) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049653/
3 (B) - https://www.ncbi.nlm.nih.gov/pubmed/28991765
4 (C) - https://www.ncbi.nlm.nih.gov/pubmed/18156403
5 (A) - https://www.ncbi.nlm.nih.gov/pubmed/28440323
6 (B) - https://www.ncbi.nlm.nih.gov/pubmed/9313662
7 (A) - https://www.ncbi.nlm.nih.gov/pubmed/10368239
8 (B) - https://www.ncbi.nlm.nih.gov/pubmed/10792163